Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Griffiths

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Cells|November 26, 2022
Survival Pathways of HIF-Deficient Tumour Cells: TCA Inhibition, Peroxisomal Fatty Acid Oxidation Activation and an AMPK-PGC-1α Hypoxia SensorMonika A Golinska, Marion Stubbs, Adrian L Harris, et al.
Open Biology|August 9, 2013
Drosophila F-BAR protein Syndapin contributes to coupling the plasma membrane and contractile ring in cytokinesisTetsuya Takeda, Iain M Robinson, Matthew M Savoian, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivoVassiliki Kostourou, Helen Troy, Joanne F Murray, et al.
Journal of Neurosurgery|July 29, 2006
Comparison between neuroimaging classifications and histopathological diagnoses using an international multicenter brain tumor magnetic resonance imaging databaseMargarida Julià-Sapé, Dionisio Acosta, Carles Majós, et al.
Neoplasia (New York, N.Y.)|April 14, 2006
Rat tumor response to the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid as measured by dynamic contrast-enhanced magnetic resonance imaging, plasma 5-hydroxyindoleacetic acid levels, and tumor necrosisLesley D McPhail, Dominick J O McIntyre, Christian Ludwig, et al.
Analytical Chemistry|July 6, 2012
An assessment of peptide enrichment methods employing mTRAQ quantification approachesDavid N Potier, John R Griffiths, Richard D Unwin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Noninvasive measurements of capecitabine metabolism in bladder tumors overexpressing thymidine phosphorylase by fluorine-19 magnetic resonance spectroscopyYuen-Li Chung, Helen Troy, Ian R Judson, et al.
Nature|December 10, 2014
A PP1-PP2A phosphatase relay controls mitotic progressionAgnes Grallert, Elvan Boke, Anja Hagting, et al.
Microvascular Research|March 15, 2006
Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126Elizabeth R Cullis, Tammy L Kalber, Susan E Ashton, et al.
Investigative Radiology|November 24, 2005
A longitudinal study of R2* and R2 magnetic resonance imaging relaxation rate measurements in murine liver after a single administration of 3 different iron oxide-based contrast agentsTammy L Kalber, Christopher J Smith, Franklyn A Howe, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Cells|November 26, 2022
Survival Pathways of HIF-Deficient Tumour Cells: TCA Inhibition, Peroxisomal Fatty Acid Oxidation Activation and an AMPK-PGC-1α Hypoxia SensorMonika A Golinska, Marion Stubbs, Adrian L Harris, et al.
Open Biology|August 9, 2013
Drosophila F-BAR protein Syndapin contributes to coupling the plasma membrane and contractile ring in cytokinesisTetsuya Takeda, Iain M Robinson, Matthew M Savoian, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivoVassiliki Kostourou, Helen Troy, Joanne F Murray, et al.
Journal of Neurosurgery|July 29, 2006
Comparison between neuroimaging classifications and histopathological diagnoses using an international multicenter brain tumor magnetic resonance imaging databaseMargarida Julià-Sapé, Dionisio Acosta, Carles Majós, et al.
Neoplasia (New York, N.Y.)|April 14, 2006
Rat tumor response to the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid as measured by dynamic contrast-enhanced magnetic resonance imaging, plasma 5-hydroxyindoleacetic acid levels, and tumor necrosisLesley D McPhail, Dominick J O McIntyre, Christian Ludwig, et al.
Analytical Chemistry|July 6, 2012
An assessment of peptide enrichment methods employing mTRAQ quantification approachesDavid N Potier, John R Griffiths, Richard D Unwin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Noninvasive measurements of capecitabine metabolism in bladder tumors overexpressing thymidine phosphorylase by fluorine-19 magnetic resonance spectroscopyYuen-Li Chung, Helen Troy, Ian R Judson, et al.
Nature|December 10, 2014
A PP1-PP2A phosphatase relay controls mitotic progressionAgnes Grallert, Elvan Boke, Anja Hagting, et al.
Microvascular Research|March 15, 2006
Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126Elizabeth R Cullis, Tammy L Kalber, Susan E Ashton, et al.
Investigative Radiology|November 24, 2005
A longitudinal study of R2* and R2 magnetic resonance imaging relaxation rate measurements in murine liver after a single administration of 3 different iron oxide-based contrast agentsTammy L Kalber, Christopher J Smith, Franklyn A Howe, et al.
Pageof 13